DOSSIER · 13F Holders · Q3 2026

CHINOOK THERAPEUTICS CVR

2 institutions still hold CHINOOK THERAPEUTICS CVR as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 169CVR016·2 13F holders·last filed Sep 30, 2026
Market cap
—
13F value held
—
visible holders
Holders
2
filers reporting
Concentration
—
RHUMBLINE ADVISERS #1
top holder share
AI Holders Summary · Q3 2026

2 institutions reported CHINOOK THERAPEUTICS CVR in Q3 2026. Top-holder concentration data is loading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
RHUMBLINE ADVISERS
CIK 0001115418
$087K0.00%Q3 2026
02
Golden State Equity Partners
CIK 0001845003
$0300.00%Q3 2026